Andersen-Tawil syndrome screening: Difference between revisions
(Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guideline nam...") |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome. | ||
OR | OR | ||
Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome. | ||
OR | OR |
Revision as of 20:41, 30 January 2020
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Andersen-Tawil syndrome screening On the Web |
American Roentgen Ray Society Images of Andersen-Tawil syndrome screening |
Risk calculators and risk factors for Andersen-Tawil syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome.
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome.
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]